Contraception

Camrese Oral Contraceptive Available

Teva announced that Camrese (levonorgestrel/ethinyl estradiol and ethinyl estradiol tablets), an oral contraceptive, is now available for the prevention of pregnancy.

Emoquette Approved for Oral Contraception

Qualitest and Endo announced that Emoquette (desogestrel and ethinyl estradiol tablets) has been approved for the prevention of pregnancy in women who elect to use oral contraceptives.

Chewable Low-Dose Oral Contraceptive approved

Watson announced that the FDA has approved a low dose oral contraceptive, which combines a 24-day active hormone regimen (0.8mg norethindrone and 25mcg ethinyl estradiol) with four tablets containing 75mg of ferrous fumarate, in chewable form.

Lo Loestrin FE oral contraceptive approved

Warner Chilcott announced that the FDA has approved Lo Loestrin FE (norethindrone acetate and ethinyl estradiol tablets, ethinyl estradiol tablets, and ferrous fumarate tablets) for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception.